The current group works on multiple techniques for spatial omics mapping. We are continuously expanding our toolsets with new designs.

Spatial Omics technology
Deterministic Barcoding in Tissue for spatial omics sequencing – for co-mapping of mRNAs and proteins in a formaldehyde-fixed tissue slide via NGS sequencing. Parallel microfluidic channels were used to deliver DNA barcodes to the surface of a tissue slide and crossflow of two sets of barcodes A1-50 and B1-50 followed by ligation in situ yielded a 2D mosaic of tissue pixels, each containing a unique full barcode AB. Read more.


Microbiome spatial omics
Our lab develops and applies innovative spatial omics technologies to investigate host–microbiome interactions in health and disease. A major focus of our research is understanding how the spatial organization and transcriptional activities of microbial communities influence host cellular responses, immune regulation, and disease progression. To address these questions, we developed microDBiT, a high-resolution spatial transcriptomics platform that enables simultaneous profiling of host and bacterial RNAs, including mRNA and rRNA, within intact tissues.. Read more.

Cancer Biology
We are conducting research to identify spatially resolved biomarkers to predict cancer progression and metastatic potential using Spatial ATAC-seq. This approach allows us to map chromatin accessibility in distinct cellular regions, providing insights into the regulatory mechanisms driving tumor growth and metastasis. By leveraging this technology, we aim to pinpoint key epigenetic changes that contribute to cancer progression.
Cardiovascular Research

We are using Spatial ATAC-seq to map chromatin accessibility in distinct cardiac regions, providing insights into the regulatory mechanisms driving heart tissue remodeling and disease progression. Our research focuses on identifying spatially resolved biomarkers that can predict heart disease progression and its potential complications. By leveraging this technology, we aim to pinpoint key epigenetic changes that contribute to cardiovascular disease.